Our findings elucidate a positive feedback loop of THAP9-AS1/miR-133b/SOX4 in facilitating ESCC progression (Fig. 8G), providing a better understanding of lncRNA-based target treatment and highlighting a valuable therapeutic strategy for ESCC. Here, SOX4 is linked to esophageal squamous cell carcinoma.